GlassScriptPhysician profile
Deepak G Nair
NPI 1841491495
$19,615.88
in general payments reported to CMS, 2019-2025
34 companies · $2,742 in 2025
The $2,742 reported for 2025 was more than what 76% of Vascular Surgery providers received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,174 · 2020: $1,663 · 2021: $2,306 · 2022: $2,712 · 2023: $4,462 · 2024: $3,555 · 2025: $2,742.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,156 · Long Term Medical Supply Or Device Loan: $2,400 · Travel and Lodging: $133 · Education: $69.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,156.07 |
| Long Term Medical Supply Or Device Loan | $2,400.00 |
| Travel and Lodging | $133.34 |
| Education | $69.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $3,379.19 | 2021-2025 | Endurant Iis, Ellipsys Vascular Access System, In.Pact Admiral |
| W. L. Gore & Associates, INC. | $2,876.92 | 2019-2025 | Gore Viabahn Vbx Balloon Expandable Endo, Gore Excluder Thoracoabdominal Branch Endoprosthesis, Gore Excluder Iliac Branch Endoprosthesis |
| Angiodynamics, INC. | $2,484.40 | 2022-2025 | Venacure 1470 Pro, Venacure 1470 Pro |
| Cook Medical LLC | $2,395.77 | 2019-2025 | Zilver Ptx, Zenith Spiral-Z, Rosen |
| Silk Road Medical, INC. | $1,414.50 | 2019-2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Abbott Laboratories | $1,412.86 | 2020-2025 | Esprit, Supera, Jeti |
| Medtronic Vascular, INC. | $1,109.74 | 2019-2020 | |
| Philips North America LLC | $731.33 | 2019-2025 | (Az7) Lasers, Igt Devices Undivided, (Br5) Peripheral Ivus |
| Janssen Pharmaceuticals, INC | $629.29 | 2019-2023 | Xarelto |
| Penumbra, INC. | $610.06 | 2022-2025 | Indigo System, Penumbra System |
| Terumo Medical Corporation | $508.11 | 2021-2023 | Azur Cx Detachable, Metacross Otw, R2p Misago |
| Boston Scientific Corporation | $319.30 | 2021-2024 | Varithena Administration Pack, Eluvia |
| Bard Peripheral Vascular, INC. | $294.85 | 2020-2025 | Venovo |
| Arthrex, INC. | $202.30 | 2021 | |
| Stryker Corporation | $147.47 | 2025 | Inthrill Thrombectomy Catheter |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $141.11 | 2019-2024 | Grafix Pl, Stravix, Collagenase Santyl |
| Organogenesis INC. | $137.11 | 2024 | Apligraf |
| Kerecis Limited | $130.59 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Cardiva Medical, INC. | $101.22 | 2023-2024 | Cardiva Vascade 6/7f Vcs |
| Venclose INC. | $98.30 | 2020 | |
| Getinge USA Sales, LLC | $87.40 | 2019-2020 | |
| Cardinal Health 200 LLC | $81.00 | 2020 | |
| Solventum Corporation | $42.49 | 2024 | Activ.A.C., Prevena, V.A.C.Instill |
| Ucb, INC. | $41.33 | 2021 | |
| Inari Medical, INC. | $40.91 | 2023-2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Cvrx, INC. | $36.04 | 2022-2023 | Barostim Neo System |
| Convatec INC. | $33.35 | 2023 | |
| Cashflow Solutions, LLC | $29.28 | 2022 | |
| Biocompatibles, INC. | $29.26 | 2019 | |
| Tactile Systems Technology INC | $23.00 | 2025 | Nimbl, Flexitouch Plus |
| Astrazeneca Pharmaceuticals LP | $19.60 | 2023 | Andexxa |
| Catheter Precision, INC. Fka Ra Medical Systems, INC. | $13.11 | 2019 | |
| Avenu Medical INC. | $11.52 | 2019 | |
| Musculoskeletal Transplant Foundation INC. | $3.17 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Deepak Nair listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.